Skip to main content
See every side of every news story
Published • loading... • Updated

Novartis Reaffirms Sales Targets as Drug Trial Results and FDA Talks Loom

Summary by MarketBeat
Novartis (NYSE:NVS) executives outlined a slate of upcoming drug-trial results and regulatory discussions across immunology, cardiovascular disease, oncology and neuroscience, while reiterating sales ambitions for several established medicines. Among the company’s priorities are securing a label fo

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Thursday, November 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal